Emerging in the landscape of weight management therapy, retatrutide is a distinct method. Beyond many existing medications, retatrutide functions as a dual agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) binding sites. The simultaneous activation fosters several beneficial effects, lik